Ancora Advisors, LLC Merck & Co., Inc. Transaction History

Ancora Advisors, LLC

  • $4.06 Billion
  • Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 29,920 shares of MRK stock, worth $2.97 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
29,920
Previous 44,607 32.93%
Holding current value
$2.97 Million
Previous $5.52 Million 38.48%
% of portfolio
0.08%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$111.15 - $128.97 $1.63 Million - $1.89 Million
-14,687 Reduced 32.93%
29,920 $3.4 Million
Q2 2024

Aug 14, 2024
BUY
$123.8 - $132.96 $26,245 - $28,187
212 Added 0.48%
44,607 $5.52 Million
Q1 2024

May 15, 2024
SELL
$113.24 - $131.95 $157,630 - $183,674
-1,392 Reduced 3.04%
44,395 $5.86 Million
Q4 2023

Feb 14, 2024
BUY
$100.18 - $109.02 $153,976 - $167,563
1,537 Added 3.47%
45,787 $4.99 Million
Q3 2023

Nov 14, 2023
BUY
$102.95 - $114.33 $31,811 - $35,327
309 Added 0.7%
44,250 $4.56 Million
Q2 2023

Aug 14, 2023
BUY
$108.61 - $118.38 $216,133 - $235,576
1,990 Added 4.74%
43,941 $5.07 Million
Q1 2023

May 15, 2023
BUY
$102.94 - $114.86 $13,896 - $15,506
135 Added 0.32%
41,951 $4.46 Million
Q4 2022

Feb 14, 2023
BUY
$87.44 - $112.11 $21,772 - $27,915
249 Added 0.6%
41,816 $4.64 Million
Q3 2022

Nov 14, 2022
SELL
$84.53 - $94.96 $132,796 - $149,182
-1,571 Reduced 3.64%
41,567 $3.58 Million
Q2 2022

Aug 15, 2022
SELL
$83.49 - $94.64 $38,739 - $43,912
-464 Reduced 1.06%
43,138 $3.93 Million
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $216,707 - $242,915
-2,948 Reduced 6.33%
43,602 $3.58 Million
Q1 2022

May 13, 2022
BUY
$73.51 - $82.4 $104,016 - $116,596
1,415 Added 3.14%
46,550 $3.59 Million
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $18,070 - $22,635
250 Added 0.56%
45,135 $3.46 Million
Q3 2021

Nov 15, 2021
BUY
$71.68 - $78.83 $6,881 - $7,567
96 Added 0.21%
44,885 $3.37 Million
Q2 2021

Aug 13, 2021
SELL
$70.31 - $77.77 $123,815 - $136,952
-1,761 Reduced 3.78%
44,789 $3.48 Million
Q1 2021

May 14, 2021
BUY
$68.86 - $81.11 $120,918 - $142,429
1,756 Added 3.92%
46,550 $3.59 Million
Q4 2020

Feb 12, 2021
BUY
$71.77 - $79.65 $21,172 - $23,496
295 Added 0.66%
44,794 $3.66 Million
Q3 2020

Nov 13, 2020
SELL
$73.18 - $82.95 $60,666 - $68,765
-829 Reduced 1.83%
44,499 $3.69 Million
Q2 2020

Aug 14, 2020
BUY
$70.42 - $80.13 $16,478 - $18,750
234 Added 0.52%
45,328 $3.51 Million
Q1 2020

May 14, 2020
SELL
$63.36 - $87.82 $18,754 - $25,994
-296 Reduced 0.65%
45,094 $3.47 Million
Q4 2019

Feb 14, 2020
BUY
$77.58 - $87.54 $46,392 - $52,348
598 Added 1.34%
45,390 $4.13 Million
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $24,193 - $26,371
-318 Reduced 0.7%
44,792 $3.77 Million
Q2 2019

Aug 12, 2019
SELL
$69.84 - $81.59 $695,257 - $812,228
-9,955 Reduced 18.08%
45,110 $3.78 Million
Q1 2019

May 15, 2019
SELL
$69.58 - $79.36 $232,953 - $265,697
-3,348 Reduced 5.73%
55,065 $4.58 Million
Q4 2018

Feb 15, 2019
SELL
$65.24 - $75.71 $72,807 - $84,492
-1,116 Reduced 1.87%
58,413 $4.46 Million
Q3 2018

Nov 13, 2018
BUY
$57.69 - $67.84 $3.43 Million - $4.04 Million
59,529 New
59,529 $4.22 Million
Q2 2018

Aug 10, 2018
SELL
$50.83 - $59.72 $1.88 Million - $2.21 Million
-37,046 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$50.96 - $59.23 $117,972 - $137,117
2,315 Added 6.67%
37,046 $2.02 Million
Q4 2017

Feb 14, 2018
BUY
$51.62 - $61.64 $48,832 - $58,311
946 Added 2.8%
34,731 $1.95 Million
Q3 2017

Nov 14, 2017
BUY
$58.67 - $63.13 $1.98 Million - $2.13 Million
33,785
33,785 $2.16 Million

Others Institutions Holding MRK

# of Institutions
3,828
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email